1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Organigram Global Inc.

Organigram Global Inc.

OGI
Organigram Global Inc.US flagNASDAQ Global Select
0.94
USD
+0.00
- -
132.63MMarket Cap

Total Valuation

Organigram Global Inc. carries a market capitalization of 132.63M, placing it among publicly traded companies globally. Its enterprise value stands at 223.89M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap132.63M
Enterprise Value223.89M

Share Statistics

Organigram Global Inc. currently has 140.98M shares outstanding.

Shares Outstanding140.98M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Organigram Global Inc. trades at a trailing price-to-earnings ratio of 2.24. The price-to-sales ratio is 0.63, and the price-to-book ratio stands at 0.42.

PE Ratio2.24
PS Ratio0.63
PB Ratio0.42
P/TBV Ratio2.34
P/FCF Ratio-7.14
P/OCF Ratio-6.80

Enterprise Valuation

On an enterprise value basis, Organigram Global Inc. trades at an EV/EBITDA multiple of 12.16 and an EV/FCF ratio of 45.90.

EV / Sales0.72
EV / EBITDA12.16
EV / EBITN/A
EV / FCF45.90

Financial Position

Organigram Global Inc. maintains a current ratio of 2.61, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

Current Ratio2.61
Quick Ratio0.93
Debt / Equity6.48
Debt / EBITDA1.71
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)19.89
Return on Assets (ROA)12.51
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)5.11
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.35

Taxes

Income Tax-5.35M
Effective Tax RateN/A

Stock Price Statistics

Organigram Global Inc.'s stock has declined approximately -45.31395% over the past 52 weeks. The 50-day moving average sits at 1.10, while the 200-day moving average is 1.23.

Beta (5Y)N/A
52-Week Price Change-45.31395%
50-Day Moving Average1.10
200-Day Moving Average1.23
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Organigram Global Inc. generated 309.18M in revenue and converted that into 86.62M in net income, yielding earnings per share of 0.64. EBITDA reached 18.41M, while operating income came in at -6.69M.

Revenue309.18M
Gross Profit112.98M
Operating Income-6.69M
Pretax Income81.27M
Net Income86.62M
EBITDA18.41M
EBIT-6.69M
Earnings Per Share (EPS)0.64

Balance Sheet

Organigram Global Inc. holds 11.67M in cash and equivalents against 31.45M in total debt, resulting in a net debt position of 6.76M. Total book value stands at 485.46M, with working capital of 172.81M providing operational flexibility.

Cash & Cash Equivalents11.67M
Total Debt31.45M
Net Debt6.76M
Equity (Book Value)485.46M
Book Value Per Share3.44
Working Capital172.81M

Cash Flow

Organigram Global Inc. produced -28.52M in operating cash flow over the past twelve months. After subtracting -1.15M in capital expenditures, free cash flow totaled -29.68M - equivalent to -0.22 per share.

Operating Cash Flow-28.52M
Capital Expenditures-1.15M
Free Cash Flow-29.68M
FCF Per Share-0.22

Margins

Organigram Global Inc. operates with a gross margin of 36.54, reflecting its pricing power and cost economics. The operating margin of -2.16 and net profit margin of 28.02 provide insight into operational efficiency.

Gross Margin36.54
Operating Margin-2.16
Pretax Margin26.29
Profit Margin28.02
EBITDA Margin5.95

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-40.99
FCF Yield-14.01

Stock Splits

Organigram Global Inc.'s most recent stock split took place on July 7, 2023 with a 4:1 split ratio.

Last Split Date7/7/2023
Split Ratio4:1

Scores

Organigram Global Inc. posts an Altman Z-Score of -0.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.07